by Tina Andersen | Aug 31, 2023 | News
31 August 2023 — Scantox A/S (“Scantox” or the “Company”), the leading Nordic GLP-compliant pre-clinical contract research organization (“CRO”), headquartered in Denmark and since 2021 owned by Impilo, is pleased to announce the acquisition of Q&Q Labs AB...
by Tina Andersen | Jul 7, 2023 | News
July 7th – Scantox Group, a leading provider of nonclinical services in Europe, has named Andy Brown as Group Chief Commercial Officer with the overall responsibility of growing sales within toxicology, discovery and lab services and fostering positive relationships...
by Tina Andersen | Jun 14, 2023 | News
Scantox is pleased to announce that we are exclusive distributors of advanced preclinical models, including the BRGSF-HIS and advanced humanized immune checkpoint models from genOway in Demark, Sweden, Norway and Finland. The genOway BRGSF-HIS mouse possesses the most...
by Tina Andersen | Apr 26, 2023 | News
Scantox is proud to be certified by Great Place to Work™. This prestigious award is based entirely on what current employees say about their experience of working at Scantox. It takes an entire team of dedicated individuals to achieve what we do at Scantox. Each...
by Tina Andersen | Jan 27, 2023 | News
At the annual New Years Celebration arranged by Connect Køge, Scantox was announced as this year’s winner of the ’Company of the Year 2022’ award. Two other nominees were in the race for the award. ”Within their specific line of business, the winning company is a...
by Tina Andersen | Nov 21, 2022 | News
Scantox Group is one of this year’s proud nominees to the title ‘Company of the Year 2022’ in the Køge area in Denmark where our HQ is located. Three companies are nominated for all having done an outstanding effort to support local initiatives in...
